Skip to main content
Veterinary Medicines

DOLPAC LARGE DOGS TABLETS

Authorised
  • Oxantel pamoate
  • Praziquantel
  • Pyrantel embonate

Product identification

Medicine name:
DOLPAC LARGE DOGS TABLETS
Dolpac 500,7 mg + 124,85 mg + 125 mg Tabletka
Active substance:
  • Oxantel pamoate
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Oxantel pamoate
    1397.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    125.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    360.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:
  • Cardboard box with 1 strip of 3 tablets
  • Cardboard box with 20 strips of 3 tablets
  • Cardboard box with 10 strips of 3 tablets
  • Cardboard box with 6 strips of 3 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1818
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0183/003
Concerned member states:
  • Austria
  • Cyprus
  • Czechia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022